ConductScience.org, home

Library / Genes

MICA: MHC class I polypeptide-related sequence A

1 protein, 145 patents, 0 drugs, 0 trials, 2,994 NIH grants and 5,986 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolMICAHGNC
NameMHC class I polypeptide-related sequence AHGNC
NCBI Gene ID100507436NCBI Gene
HGNC IDHGNC:7090HGNC
EnsemblENSG00000204520NCBI Gene
AliasesMIC-A, PERB11.1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
Q29983MHC class I polypeptide-related sequence A38310GeneID, HGNCUniProt

Patents 145

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026021336 A2026-02-109Q29983Espacenet
JP 2026004568 A2026-01-1453433Q29983Espacenet
JP 2026004568 A2026-01-1453450Q29983Espacenet
JP 2026500896 A2026-01-0923Q29983Espacenet
WO 2025235604 A12025-11-1323Q29983Espacenet
WO 2025235605 A12025-11-1323Q29983Espacenet
JP 2025147176 A2025-10-0617032Q29983Espacenet
JP 2025147176 A2025-10-0617033Q29983Espacenet
JP 2025076449 A2025-05-1531Q29983Espacenet
WO 2025085672 A12025-04-247Q29983Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2994

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant202,025NIH's project files
P30CA016056Roswell Park Cancer Center Support Grant202,025NIH's project files
P30CA016672Cancer Center Support Grant202,025NIH's project files
P30CA023108Cancer Center Support Grant122,025NIH's project files
P01CA018029Adult Leukemia Research Center112,025NIH's project files
P01CA111412NK cells, their receptors and cancer therapy102,025NIH's project files
P30CA006927Comprehensive Cancer Center Program at Fox Chase102,025NIH's project files
P30CA047904Cancer Center Support Grant102,025NIH's project files
P50CA097190Head and Neck Cancer SPORE102,025NIH's project files
R01DK032083Multiple Autoantigens, Multiple Epitopes of Type 1 Diabetes102,025NIH's project files

Papers 5986

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42783407PubTator, text miningPubMed
42745720PubTator, text miningPubMed
42699700PubTator, text miningPubMed
42634225PubTator, text miningPubMed
42628384PubTator, text miningPubMed
42615342PubTator, text miningPubMed
42548496PubTator, text miningPubMed
42536179PubTator, text miningPubMed
42510799PubTator, text miningPubMed
42509680PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license